Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 216

1.

Abnormal neurotransmitter metabolite levels in Alzheimer patients with a delirium.

van der Cammen TJ, Tiemeier H, Engelhart MJ, Fekkes D.

Int J Geriatr Psychiatry. 2006 Sep;21(9):838-43.

PMID:
16955437
[PubMed - indexed for MEDLINE]
2.

Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease.

Molina JA, Jiménez-Jiménez FJ, Vargas C, Gómez P, de Bustos F, Ortí-Pareja M, Tallón-Barranco A, Benito-León J, Arenas J, Enríquez-de-Salamanca R.

J Neural Transm. 1998;105(2-3):279-86.

PMID:
9660106
[PubMed - indexed for MEDLINE]
3.

Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.

Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, Soto-Hernandez JL, Flores-Hernandez R, Nente F, Montes S, Rios C.

Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):337-43. doi: 10.1016/j.genhosppsych.2008.01.007.

PMID:
18585537
[PubMed - indexed for MEDLINE]
4.

Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease.

Jiménez-Jiménez FJ, Molina JA, Gómez P, Vargas C, de Bustos F, Benito-León J, Tallón-Barranco A, Ortí-Pareja M, Gasalla T, Arenas J.

J Neural Transm. 1998;105(2-3):269-77.

PMID:
9660105
[PubMed - indexed for MEDLINE]
5.

Peripheral serotonin in Alzheimer's disease.

Kumar AM, Sevush S, Kumar M, Ruiz J, Eisdorfer C.

Neuropsychobiology. 1995;32(1):9-12.

PMID:
7566524
[PubMed - indexed for MEDLINE]
6.

Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.

Kawakatsu S, Morinobu S, Shinohara M, Totsuka S, Kobashi K.

Biol Psychiatry. 1990 Sep 1;28(5):387-400.

PMID:
1698467
[PubMed - indexed for MEDLINE]
7.

5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.

Stuerenburg HJ, Ganzer S, Müller-Thomsen T.

Neuro Endocrinol Lett. 2004 Dec;25(6):435-7.

PMID:
15665806
[PubMed - indexed for MEDLINE]
8.

Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.

Nazarali AJ, Reynolds GP.

Cell Mol Neurobiol. 1992 Dec;12(6):581-7.

PMID:
1283363
[PubMed - indexed for MEDLINE]
9.

Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease.

Rubio JC, de Bustos F, Molina JA, Jiménez-Jiménez FJ, Benito-León J, Martín MA, Campos Y, Ortí-Pareja M, Cabrera-Valdivia F, Arenas J.

J Neurol Sci. 1998 Mar 5;155(2):192-5.

PMID:
9562266
[PubMed - indexed for MEDLINE]
10.

Neurotransmitter precursor amino acids in the treatment of multi-infarct dementia and Alzheimer's disease.

Meyer JS, Welch KM, Deshmukh VD, Perez FI, Jacob RH, Haufrect DB, Mathew NT, Morrell RM.

J Am Geriatr Soc. 1977 Jul;25(7):289-98.

PMID:
301148
[PubMed - indexed for MEDLINE]
11.

CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.

Markianos M, Lafazanos S, Koutsis G, Sfagos C, Seretis A.

Clin Neurol Neurosurg. 2009 Apr;111(3):231-4. doi: 10.1016/j.clineuro.2008.10.001. Epub 2008 Nov 28.

PMID:
19046799
[PubMed - indexed for MEDLINE]
12.

Altered cerebrospinal fluid amino acid pattern in the anorexia of aging: relationship with biogenic amine metabolism.

Martinez M, Arnalich F, Vazquez JJ, Hernanz A.

Life Sci. 1993;53(21):1643-50.

PMID:
7694027
[PubMed - indexed for MEDLINE]
13.

A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium.

Koponen HJ, Lepola U, Leinonen E.

Eur Arch Psychiatry Clin Neurosci. 1994;244(3):131-4.

PMID:
7528542
[PubMed - indexed for MEDLINE]
14.

Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.

Losonczy MF, Mohs RC, Davis KL.

Psychiatry Res. 1984 May;12(1):79-87.

PMID:
6205414
[PubMed - indexed for MEDLINE]
15.

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia.

Fekkes D, van der Cammen TJ, van Loon CP, Verschoor C, van Harskamp F, de Koning I, Schudel WJ, Pepplinkhuizen L.

J Neural Transm. 1998;105(2-3):287-94.

PMID:
9660107
[PubMed - indexed for MEDLINE]
16.

Delirium in Alzheimer disease.

Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP.

Alzheimer Dis Assoc Disord. 1997 Mar;11(1):16-20.

PMID:
9071440
[PubMed - indexed for MEDLINE]
17.

Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.

Mitani H, Shirayama Y, Yamada T, Kawahara R.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):531-4. Epub 2006 Jan 18.

PMID:
16414168
[PubMed - indexed for MEDLINE]
18.

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites.

Pomara N, Singh RR, Deptula D, LeWitt PA, Bissette G, Stanley M, Nemeroff CB.

Biol Psychiatry. 1989 Sep;26(5):500-4.

PMID:
2477071
[PubMed - indexed for MEDLINE]
19.

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

Peskind ER, Wingerson D, Murray S, Pascualy M, Dobie DJ, Le Corre P, Le Verge R, Veith RC, Raskind MA.

Arch Gen Psychiatry. 1995 Sep;52(9):774-82.

PMID:
7654129
[PubMed - indexed for MEDLINE]
20.

Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease.

Ravaglia G, Forti P, Maioli F, Bianchi G, Martelli M, Talerico T, Servadei L, Zoli M, Mariani E.

Am J Clin Nutr. 2004 Aug;80(2):483-8.

PMID:
15277174
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk